Swallowed Fluticasone Improves Histologic but Not Symptomatic Response of Adults With Eosinophilic Esophagitis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 7, 2012, Pages 742-749.e1

  Alexander, Jeffrey A ^a   Jung, Kee Wook ^d   Arora, Amindra S ^a   Enders, Felicity ^b   Katzka, David A ^a   Kephardt, Gail M ^c   Kita, Hirohito ^c   Kryzer, Lori A ^a   Romero, Yvonne ^a   Smyrk, Thomas C ^b   Talley, Nicholas J ^e  

^a MAYO CLINIC   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d Asan Medical Center   (South Korea)

^e UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Dysphagic; EDN; Esophagus; Steroid treatment

Indexed keywords

FLUTICASONE; NEUROTOXIN; PLACEBO;

ADULT; ALLERGY; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPHAGIA; EOSINOPHIL COUNT; EOSINOPHILIA; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS CANDIDIASIS; EVALUATION; FEMALE; FOOD REGURGITATION; HOARSENESS; HUMAN; HUMAN TISSUE; MALE; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SORE THROAT; THRUSH; TREATMENT RESPONSE;

EID: 84862690562     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.03.018     Document Type: Article

References (26)

1. Landres R.T., Kuster G.G., Strum W.B. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology 1978, 74:1298-1301.
2. Sgouros S.N., Bergele C., Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol 2006, 18:211-217.
3. Noel R.J., Putnam P.E., Rothenberg M.E. Eosinophilic esophagitis. N Engl J Med 2004, 351:940-941.
4. Liacouras C.A., Furuta G.T., Hirano I., et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011, 128:3-20.e6. quiz, 21-22.
5. Bohm M., Richter J.E. Treatment of eosinophilic esophagitis: overview, current limitations, and future direction. Am J Gastroenterol 2008, 103:2635-2644. quiz, 2645.
6. Molina-Infante J., Ferrando-Lamana L., Ripoll C., et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011, 9:110-117.
7. Arora A.S., Perrault J., Smyrk T.C. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 2003, 78:830-835.
8. Remedios M., Campbell C., Jones D.M., et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006, 63:3-12.
9. Teitelbaum J.E., Fox V.L., Twarog F.J., et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002, 122:1216-1225.
10. Konikoff M.R., Noel R.J., Blanchard C., et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006, 131:1381-1391.
11. Aceves S.S., Bastian J.F., Newbury R.O., et al. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 2007, 102:2271-2279. quiz, 2280.
12. Straumann A., Conus S., Degen L., et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010, 139:1526-1537.
13. Dohil R., Newbury R., Fox L., et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010, 139:418-429.
14. McElhiney J., Lohse M.R., Arora A.S., et al. The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia 2010, 25:221-230.
15. Grudell A.B., Alexander J.A., Enders F.B., et al. Validation of the Mayo Dysphagia Questionnaire. Dis Esophagus 2007, 20:202-205.
16. Gonsalves N., Policarpio-Nicolas M., Zhang Q., et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006, 64:313-319.
17. Borrego L., Maynard B., Peterson E.A., et al. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 1996, 148:897-909.
18. Kephart G.M., Alexander J.A., Arora A.S., et al. Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis. Am J Gastroenterol 2009, 105:298-307.
19. Straumann A., Conus S., Degen L., et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011, 9:400-409.e1.
20. Kwiatek M.A., Hirano I., Kahrilas P.J., et al. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology 2011, 140:82-90.
21. Nguyen K.L., Lauver D., Kim I., et al. The effect of a steroid "burst" and long-term, inhaled fluticasone propionate on adrenal reserve. Ann Allergy Asthma Immunol 2003, 91:38-43.
22. Mahachoklertwattana P., Sudkronrayudh K., Direkwattanachai C., et al. Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate. Arch Dis Child 2004, 89:1055-1058.
23. Taylor R.L., Machacek D., Singh R.J. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem 2002, 48:1511-1519.
24. Korpi-Steiner N.L., Netzel B.C., Seegmiller J.C., et al. Liquid chromatography-tandem mass spectrometry analysis of urinary fluticasone propionate-17beta-carboxylic acid for monitoring compliance with inhaled-fluticasone propionate therapy. Steroids 2010, 75:77-82.
25. Ravi K., Talley N.J., Smyrk T.C., et al. Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis?. Dig Dis Sci 2011, 56:1981-1986.
26. Furuta G.T., Liacouras C.A., Collins M.H., et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007, 133:1342-1363.